General American Investors CO Inc Regeneron Pharmaceuticals, Inc. Transaction History

General American Investors CO Inc

$1.39 Billion
Q4 2024

A detailed history of General American Investors CO Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, General American Investors CO Inc holds 14,876 shares of REGN stock, worth $10.4 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

14,876

Previous 11,876 25.26%

Holding current value

$10.4 Million

Previous $12.5 Million 15.12%

% of portfolio

0.76%

Previous 0.89%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$701.85 - $1046.91 $2.11 Million - $3.14 Million	3,000 Added 25.26%	14,876 $10.6 Million
Q3 2024 Oct 31, 2024	SELL	$1024.09 - $1201.76 $2.77 Million - $3.24 Million	-2,700 Reduced 18.52%	11,876 $12.5 Million
Q1 2024 May 03, 2024	SELL	$902.69 - $993.35 $1.81 Million - $1.99 Million	-2,000 Reduced 12.07%	14,576 $14 Million
Q2 2023 Aug 03, 2023	BUY	$700.03 - $830.35 $1.05 Million - $1.25 Million	1,500 Added 9.95%	16,576 $11.9 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $2.12 Million - $2.3 Million	-3,000 Reduced 16.6%	15,076 $10.9 Million
Q3 2022 Oct 31, 2022	SELL	$573.97 - $724.32 $1.72 Million - $2.17 Million	-3,000 Reduced 14.23%	18,076 $12.5 Million
Q2 2022 Aug 05, 2022	SELL	$548.35 - $738.84 $1.1 Million - $1.48 Million	-2,000 Reduced 8.67%	21,076 $12.5 Million
Q1 2022 May 02, 2022	SELL	$595.12 - $698.43 $4.17 Million - $4.89 Million	-7,000 Reduced 23.27%	23,076 $16.1 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $7.65 Million - $9.44 Million	14,075 Added 87.96%	30,076 $19 Million
Q3 2021 Nov 01, 2021	BUY	$574.03 - $680.96 $1.72 Million - $2.04 Million	3,000 Added 23.08%	16,001 $9.68 Million
Q2 2021 Aug 05, 2021	BUY	$472.8 - $558.54 $709,200 - $837,810	1,500 Added 13.04%	13,001 $7.26 Million
Q1 2021 May 03, 2021	BUY	$446.73 - $548.2 $5.14 Million - $6.3 Million	11,501 New	11,501 $5.44 Million

Others Institutions Holding REGN

# of Institutions

1,493

Shares Held

85.8M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of General American Investors CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on General American Investors CO Inc with notifications on news.

Account

General American Investors CO Inc Regeneron Pharmaceuticals, Inc. Transaction History